Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lucira Health Inc (LHDX)

Lucira Health Inc (LHDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,140
  • Shares Outstanding, K 40,106
  • Annual Sales, $ 93,060 K
  • Annual Income, $ -64,830 K
  • 60-Month Beta 3.75
  • Price/Sales 0.08
  • Price/Cash Flow N/A
  • Price/Book 0.30
Trade LHDX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.55
  • Most Recent Earnings $-0.38 on 11/14/22
  • Latest Earnings Date 03/09/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.33
  • Number of Estimates 1
  • High Estimate -0.33
  • Low Estimate -0.33
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -1,000.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1126 +301.69%
on 02/23/23
1.4500 -68.81%
on 03/01/23
+0.1125 (+33.11%)
since 02/03/23
3-Month
0.1080 +318.80%
on 12/30/22
1.4500 -68.81%
on 03/01/23
+0.0886 (+24.36%)
since 12/02/22
52-Week
0.1080 +318.80%
on 12/30/22
4.5100 -89.97%
on 03/04/22
-4.0677 (-89.99%)
since 03/03/22

Most Recent Stories

More News
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11

Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its

LHDX : 0.4523 (-19.23%)
ABT : 113.88 (+0.35%)
GM : 45.38 (+1.77%)
GMM-U.TO : 43.32 (-1.23%)
PFE : 27.84 (+0.22%)
QDEL : 47.98 (-0.58%)
GPS : 27.49 (+0.73%)
BDX : 248.05 (+0.62%)
HTZ : 7.86 (-2.84%)
The Zacks Analyst Blog Highlights AppHarvest, Lucira Health, Lucid Group, Life Time Group and Ameriprise Financial

AppHarvest, Lucira Health, Lucid Group, Life Time Group and Ameriprise Financial are included in this Analyst Blog.

AMP : 439.86 (+0.89%)
APPH : 0.0666 (-16.02%)
LHDX : 0.4523 (-19.23%)
LCID : 2.84 (-4.38%)
LTH : 15.49 (+0.52%)
5 Big Winners as Wall Street Wraps Up Strong January Gains

AppHarvest (APPH), Lucira Health (LHDX), Lucid Group (LCID), Life Time Group (LTH) & Ameriprise Financial (AMP) not only have made the most of the January rally but also are poised to gain further this...

AMP : 439.86 (+0.89%)
APPH : 0.0666 (-16.02%)
LHDX : 0.4523 (-19.23%)
LCID : 2.84 (-4.38%)
LTH : 15.49 (+0.52%)
Aurora Cannabis Inc. (ACB) Reports Q1 Loss, Misses Revenue Estimates

Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of 11.11% and 2.78%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ACB : 4.32 (-9.05%)
LHDX : 0.4523 (-19.23%)
SurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates

SurModics (SRDX) delivered earnings and revenue surprises of 31.58% and 4.64%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

SRDX : 29.49 (+2.40%)
LHDX : 0.4523 (-19.23%)
Lucira Health, Inc. (LHDX) Q2 2022 Earnings Call Transcript

LHDX earnings call for the period ending June 30, 2022.

LHDX : 0.4523 (-19.23%)
Lucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu Test

EMERYVILLE, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical...

LHDX : 0.4523 (-19.23%)
Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Lag Estimates

Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of -50.16% and 31.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

EGRX : 5.28 (+5.39%)
LHDX : 0.4523 (-19.23%)
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 6.67% and 4.79%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

MYO : 3.28 (-6.29%)
LHDX : 0.4523 (-19.23%)
Lucira Health to Announce Second Quarter 2022 Financial Results

EMERYVILLE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the...

LHDX : 0.4523 (-19.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.

See More

Key Turning Points

3rd Resistance Point 0.6902
2nd Resistance Point 0.6341
1st Resistance Point 0.5432
Last Price 0.4523
1st Support Level 0.3962
2nd Support Level 0.3401
3rd Support Level 0.2492

See More

52-Week High 4.5100
Fibonacci 61.8% 2.8284
Fibonacci 50% 2.3090
Fibonacci 38.2% 1.7896
Last Price 0.4523
52-Week Low 0.1080

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar